Dutta Anupriya, Uno Hajime, Holman Alex, Lorenz David R, Gabuzda Dana
Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Center for Life Science 1010, 450 Brookline Avenue, Boston, MA, 02215, USA.
Department of Population Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Cancer Causes Control. 2017 Jul;28(7):767-777. doi: 10.1007/s10552-017-0896-9. Epub 2017 Apr 27.
African American men have the highest incidence of prostate cancer among ethnic groups, and racial disparity is highest in younger men. Prostate cancer prevalence is rising in HIV-infected men due to improved survival on antiretroviral therapies, yet little is known about racial differences in prostate cancer risk by HIV-infection status and age.
This is a prospective cohort study of prostate cancer risk in 2,800 HIV-infected and -uninfected men who have sex with men (MSM) aged 40-70 years (22% African American) who were enrolled in the multicenter AIDS cohort study from 1996 to 2010. Poisson regression models were used to examine associations between race and HIV-infection status and prostate cancer risk among men aged 40-70, 40-55, and 56-70 years.
Among men aged 40-70 years, incidence rates (IR) per 100,000 person-years were 169 among all men and 276 among African American HIV-infected men. Prostate cancer risk was similar by HIV-infection status (IRR 1.0, 95% CI 0.55-1.82), but nearly threefold higher in African Americans compared to non-African Americans in adjusted models (IRRs 2.66 and 3.22, 95% CIs 1.36-5.18 and 1.27-8.16 for all or HIV-infected men, respectively). Racial disparity in prostate cancer risk was greatest in African American men aged 40-55 years (adjusted IRR 3.31, 95% CI 1.19-9.22). Prostate cancer risk showed associations with family history of prostate cancer (p = 0.001), but not heavy smoking, androgen supplement use, or HIV-related factors.
Among MSM, African American HIV-positive and HIV-negative men aged 40-55 years have threefold increased risk of young-onset prostate cancer compared to non-African American men, highlighting the need to make informed decisions about screening in this population.
在不同种族群体中,非裔美国男性的前列腺癌发病率最高,且种族差异在年轻男性中最为显著。由于抗逆转录病毒疗法提高了生存率,感染艾滋病毒的男性中前列腺癌患病率正在上升,但对于按艾滋病毒感染状况和年龄划分的前列腺癌风险的种族差异知之甚少。
这是一项对2800名年龄在40 - 70岁之间与男性发生性关系的艾滋病毒感染和未感染男性(男男性行为者,MSM)进行的前瞻性队列研究(其中22%为非裔美国人),这些男性于1996年至2010年参加了多中心艾滋病队列研究。采用泊松回归模型来检验40 - 70岁、40 - 55岁和56 - 70岁男性中种族与艾滋病毒感染状况和前列腺癌风险之间的关联。
在40 - 70岁的男性中,每10万人年的发病率在所有男性中为169例,在感染艾滋病毒的非裔美国男性中为276例。前列腺癌风险在不同艾滋病毒感染状况下相似(发病率比[IRR]为1.0,95%置信区间[CI]为0.55 - 1.82),但在调整模型中,非裔美国人的风险比非非裔美国人高出近三倍(所有男性或感染艾滋病毒男性的IRR分别为2.66和3.22,95% CI分别为1.36 - 5.18和1.27 - 8.16)。前列腺癌风险的种族差异在40 - 55岁的非裔美国男性中最为显著(调整后的IRR为3.31,95% CI为1.19 - 9.22)。前列腺癌风险与前列腺癌家族史相关(p = 0.001),但与大量吸烟、使用雄激素补充剂或艾滋病毒相关因素无关。
在男男性行为者中,40 - 55岁感染艾滋病毒和未感染艾滋病毒的非裔美国男性患早发性前列腺癌的风险比非非裔美国男性高出两倍,这凸显了在该人群中做出关于筛查的明智决策的必要性。